Li Min, She Quan, Tu Junlan, Sun Sibo, Zhao Hongye, Wang Yu, Wang Kai, Zhao Weihong, Huang Peng, Chen Bo, Wu Jianqing
Jiangsu Provincial Key Laboratory of Geriatrics, Department of Geriatrics, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China.
Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
Heliyon. 2023 Apr 25;9(5):e15764. doi: 10.1016/j.heliyon.2023.e15764. eCollection 2023 May.
Frailty is a clinical syndrome and common phenomenon in the elderly, particularly when it coexists with chronic obstructive pulmonary disease (COPD). However, the relationship between frailty and its prognosis in COPD patients has not been clearly elucidated.
We collected electronic data of inpatients who were diagnosed with COPD in the First Affiliated Hospital with Nanjing Medical University (NJMU) from January 2018 to December 2020. In further, we divided them into different groups based on Frailty Index Common Laboratory Tests (FI-LAB). Binary logistic regression was performed to analyze the risk factors associated with COPD. The receiver operating characteristic (ROC) curve and area under the curve (AUC) were applied to validate FI-LAB's value in prognosis. Primary clinical outcomes contained 30-day mortality and readmission. Moreover, we also compared the prognositic value of FI-LAB with Hospital Frailty Risk Score (HRS) by ROC curve, significance was set at P < 0·05.
The final study included 826 COPD patients, among of them, 30-day mortality and readmission of frailty group was 11·2%, 25·9%, the robust group was 4·3%, 16·0%, and p value was 0·001, 0·004 respectively. Multivariate analysis revealed that smoking, CCI≥3, oral drug≥5, pneumonia, abnormal lymphocyte, abnormal haemoglobin were independent risk factors with frailty. As for the prediction of FI-LAB about frailty in 30-day mortality, the AUC was 0·832, and 30-day readmission was 0·661. As for the prognositic value, FI-LAB and HRS showed no difference in predicting clinical outcomes.
COPD individuals have a higher rate of frailty and pre-frailty. There exists a strong correlation between frailty and 30-day mortality in COPD patients, and FI-LAB has good prognostic value in clinical outcomes of patients with COPD.
衰弱是一种临床综合征,在老年人中是常见现象,尤其是当它与慢性阻塞性肺疾病(COPD)共存时。然而,COPD患者中衰弱与其预后之间的关系尚未明确阐明。
我们收集了2018年1月至2020年12月在南京医科大学第一附属医院被诊断为COPD的住院患者的电子数据。进一步地,我们根据衰弱指数常见实验室检查(FI-LAB)将他们分为不同组。进行二元逻辑回归分析与COPD相关的危险因素。应用受试者工作特征(ROC)曲线和曲线下面积(AUC)来验证FI-LAB在预后方面的价值。主要临床结局包括30天死亡率和再入院率。此外,我们还通过ROC曲线比较了FI-LAB与医院衰弱风险评分(HRS)的预后价值,显著性设定为P < 0·05。
最终研究纳入了826例COPD患者,其中衰弱组的30天死亡率和再入院率分别为11·2%、25·9%,强健组为4·3%、16·0%,P值分别为0·001、0·004。多因素分析显示,吸烟、CCI≥3、口服药物≥5种、肺炎、淋巴细胞异常、血红蛋白异常是与衰弱相关的独立危险因素。至于FI-LAB对30天死亡率中衰弱的预测,AUC为0·832,30天再入院率为0·661。在预后价值方面,FI-LAB和HRS在预测临床结局上无差异。
COPD个体衰弱和衰弱前期的发生率较高。COPD患者中衰弱与30天死亡率之间存在很强的相关性,并且FI-LAB在COPD患者的临床结局方面具有良好的预后价值。